Stockreport

Geron Secures $250M Funding and Strong Q3 Sales [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF Pharmakon Advisors and a synthetic royalty deal with Royalty Pharma, strengthening its financial position. This includes a $125 million loan tranche and $125 million fro [Read more]